The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy

BACKGROUND: T cell depleting antibody therapy with rabbit anti-thymocyte globulin (rATG) is the treatment of choice for glucocorticoid-resistant acute kidney allograft rejection (AR) and is used as first-line therapy in severe AR. Almost all studies investigating the effectiveness of rATG for this i...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zwan, Marieke, Clahsen-Van Groningen, Marian C., Roodnat, Joke I., Bouvy, Anne P., Slachmuylders, Casper L., Weimar, Willem, Baan, Carla C., Hesselink, Dennis A., Kho, Marcia M.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248318/
https://www.ncbi.nlm.nih.gov/pubmed/30115901
http://dx.doi.org/10.12659/AOT.909646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248318/
https://www.ncbi.nlm.nih.gov/pubmed/30115901
http://dx.doi.org/10.12659/AOT.909646

Ejemplares similares